In English
|
Suomeksi
Suomeksi
Extranet
Why Finland
Value of medicines
Health through innovation
Working and functional capacity
Savings in overall expenditure
Economic growth through the health sector
R&D
Research environment Finland
Research generates wellbeing
Pharmaceutical research and product development
Clinical trials of medicinal products
Register-based studies
RWD studies
Medicines
Hospital medicines
Vaccines
Development of vaccines
Self-care medicines
Biological medicines
Biosimilars
Marketing authorisation
Medicine prices
Reimbursability of medicines
Distribution of pharmaceuticals
Responsibility
Pharmaceutical manufacturing
Medicines safety
Medicines verification system
Marketing
Ground rules for marketing
Supervision of pharmaceutical marketing
Cooperation with healthcare professionals
Medicines and the environment
Pharmaceutical industry – branch of top notch experts
Joint fight against antibiotic resistance
We are
We influence
This is what we do
PIF members
Member companies
The PIF Board
Statistics
Newsroom
News
Blogs
Events
Statistics
Contact
Personnel
Media contacts
Feedback
Search
Why Finland
Value of medicines
Health through innovation
Working and functional capacity
Savings in overall expenditure
Economic growth through the health sector
R&D
Research environment Finland
Research generates wellbeing
Pharmaceutical research and product development
Clinical trials of medicinal products
Register-based studies
RWD studies
Medicines
Hospital medicines
Vaccines
Development of vaccines
Self-care medicines
Biological medicines
Biosimilars
Marketing authorisation
Medicine prices
Reimbursability of medicines
Distribution of pharmaceuticals
Responsibility
Pharmaceutical manufacturing
Medicines safety
Medicines verification system
Marketing
Ground rules for marketing
Supervision of pharmaceutical marketing
Cooperation with healthcare professionals
Medicines and the environment
Pharmaceutical industry – branch of top notch experts
Joint fight against antibiotic resistance
We are
We influence
This is what we do
PIF members
Member companies
The PIF Board
Statistics
Newsroom
News
Blogs
Events
Statistics
Contact
Personnel
Media contacts
Feedback
In English
Suomeksi
Extranet
Finland is a land of interesting prospects and competitive advantages for the pharmaceutical industry.
Why Finland
News
How can society benefit from clinical drug trials conducted in Finland?
News
Pharma industry's investments in Finland clearly increased in 2023
News
New Managing Director of PIF is Anne-Mari Virolainen
Contact us
Pharmaca
Finnish Medicines Vertification System
